| Symbol | DYAI |
|---|---|
| Name | DYADIC INTERNATIONAL INC |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 1044 NORTH U.S. HIGHWAY ONE, JUPITER, FL 33477 |
| Telephone | 561-743-8333 |
| Fax | — |
| — | |
| Website | https://www.dyadic.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001213809 |
| Description | Dyadic International Inc is a biotechnology company engaged in the discovery, development, manufacturing and selling of enzymes and other proteins for the bioenergy, biochemical, industrial enzyme and biopharmaceutical industries. Additional info from NASDAQ: |
Dyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement
Read moreDyadic Expands Commercial Non-Animal Dairy Pipeline Through New Strategic Development Agreement
Read moreDyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026
Read moreDyadic to Report Q2 2026 Financial Results and Host Conference Call on Wednesday August 12, 2026
Read moreDyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
Read moreDyadic Develops Stable C1 Cell Lines and Produces Purified Scripps-Designed Bundibugyo Ebola Antigens from Plasmids in Approximately 15 Days
Read moreFrancisco Trust under agreement dated February 28, 1996 🔴 sold 95.4K shares of DYADIC INTERNATIONAL INC (DYAI) at $1.33 Transaction Date: Jul 22, 2026 | Filing ID: 034613
Read more